EurekaMag.com logo
+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers



Breeding of the gad-mdx mouse: influence of genetically induced denervation on dystrophic muscle fibers



Laboratory Animal Science 44(1): 42-46



A new double mutant mouse strain, gad-mdx, was established. The transmission of mdx and gad genes was monitored by determining their chemical markers, creatine kinase activity and phosphoglucomutase-1 isoenzyme, respectively, in blood samples. This new strain was characterized by high creatine kinase activity in the plasma, lack of dystrophin in the muscle, and the presence of axonal swellings in the neural tissue. Although the body weight and the limb muscle size of the mutant mice were significantly lower than those of either gad or mdx mice, the clinical signs were not evident until the animals were 80 days old. After that time, the disease followed the course seen in the gad strain, and muscle weakness was exhibited in the advanced stages. Histologic examination revealed that the prevalence of muscle fiber necrosis, a deleterious consequence of the mdx gene, was significantly lower in the double mutant strain than in the mdx strain. These results supported the idea that small-caliber muscle fibers, which are induced by gad gene expression, are resistant to dystrophic necrosis. We believe that this double mutant strain will be valuable for the analysis of neural influence on diseased muscle fibers, and that it will also provide an opportunity for the testing of new therapeutic strategies for human Duchenne muscular dystrophy.

(PDF emailed within 1 workday: $29.90)

Accession: 008245460

Download citation: RISBibTeXText

PMID: 8007658



Related references

Immobilization of dystrophic mouse muscle prevents pathology and necrosis of muscle fibers. Muscle & Nerve 6(3): 234-235, 1983

Capillaries with fenestrations around regenerating muscle fibers in the soleus muscle of the dystrophic (dy) mouse. Journal of Orthopaedic Science 3(1): 67-70, 1998

Complete rescue of genetically dystrophic muscle in mouse chimeras. Federation Proceedings 36(3): 555, 1977

Visualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: Evidence of apoptosis in dystrophin-deficient muscle. Journal of Biochemistry (Tokyo) 118(5): 959-964, 1995

Development of normal and genetically dystrophic mouse muscle in tissue culture. I. Prefusion and fusion activities of muscle cells: phase contrast and time lapse study. Experimental Cell Research 80(2): 251-264, 1973

Chimera mouse study shows absence of disease in genetically dystrophic muscle. Nature (London) 248(5449): 561-564, 1974

Maturational defects of muscle fibers in the muscular dystrophic mouse. Congenital Anomalies 21(3): 253-260, 1981

Patterns of repair of dystrophic mouse muscle: studies on isolated fibers. Developmental Dynamics 216(3): 244-256, 1999

Visualization of dystrophic muscle fibers by Evans blue-vital staining in the MDX mouse. Molecular Biology of the Cell 5(SUPPL ): 27A, 1994

Effects of pH on membrane resistance in normal and dystrophic mouse skeletal muscle fibers. Experimental Neurology 82(1): 203-214, 1983

The influence of denervation on DNA content in skeletal muscle fibers. Cell Biology International Reports 5(9): 845-849, 1981

Necrotic extrafusal muscle fibers of the dystrophic mutant mouse: the ultrastructure of the myoneural junction. Anatomical Record 197(4): 397-411, 1980

Electro mechanical and morphological observation on single muscle fibers in developing dystrophic mouse. Experimental Neurology 62(1): 214-229, 1978